<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38819528</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Beyond the acute: pain in long COVID survivors at 1.5 years.</ArticleTitle><Pagination><StartPage>4109</StartPage><EndPage>4117</EndPage><MedlinePgn>4109-4117</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-024-07620-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Long COVID, characterized by persistent symptoms post-acute COVID-19, remains a subject of intense investigation. This study focuses on pain, a common and notable symptom reported by long COVID patients.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A cohort of 191 individuals, initially diagnosed with mild-to-moderate COVID-19, was followed up 1.5 years later to assess the frequency, clinical characteristics, and factors associated with pain persistence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our study revealed that 31.9% of participants experienced at least one persistent pain symptom after 1.5 years. Headache emerged as the most prevalent symptom (29.8%), followed by myalgia (5.8%) and neuropathic pain (4.2%). Factors such as female gender and the presence of neuropathic pain symptom were identified as predictors of long-term headaches. Myalgia, showed associations with headache, arthralgia, and low ferritin levels. Persistent neuropathic pain symptom (4.2%) was linked to older age, female gender, sore throat, and headache.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study provides insights into the evolution of pain symptoms over time after COVID-19 infection, emphasizing the interconnection between different pain syndromes. This research contributes to understanding the diverse and evolving nature of pain in long COVID survivors, offering valuable insights for targeted interventions and further investigations into the underlying mechanisms of persistent pain.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oguz-Akarsu</LastName><ForeName>Emel</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0465-4218</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey. emeloguz@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gullu</LastName><ForeName>Gizem</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kilic</LastName><ForeName>Erhan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Din&#xe7;</LastName><ForeName>Yasemin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akdag</LastName><ForeName>Gonul</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Kutahya Health Sciences University, Kutahya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehber</LastName><ForeName>Cansu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karli</LastName><ForeName>Necdet</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="Y">Headache</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009437" MajorTopicYN="N">Neuralgia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Headache</Keyword><Keyword MajorTopicYN="N">Myalgia</Keyword><Keyword MajorTopicYN="N">Neuropathic pain symptom</Keyword><Keyword MajorTopicYN="N">Pain</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword></KeywordList><CoiStatement>None of the authors has any conflict of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>7</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38819528</ArticleId><ArticleId IdType="pmc">PMC11306299</ArticleId><ArticleId IdType="doi">10.1007/s10072-024-07620-7</ArticleId><ArticleId IdType="pii">10.1007/s10072-024-07620-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mahase E (2020) Covid-19: what do we know about long covid? BMJ 14:370</Citation><ArticleIdList><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Foer D, MacPhaul E, Lo Y-C, Bates DW, Zhou L (2022) PASCLex: a comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes. J Biomed Inf 125:10395110.1016/j.jbi.2021.103951</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2021.103951</ArticleId><ArticleId IdType="pmc">PMC8590503</ArticleId><ArticleId IdType="pubmed">34785382</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M, Del Gaudio A, Vittori A et al (2021) COVID-pain: acute and late-onset painful clinical manifestations in COVID-19&#x2013;molecular mechanisms and research perspectives. J Pain Res 10:2403&#x2013;241210.2147/JPR.S313978</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S313978</ArticleId><ArticleId IdType="pmc">PMC8364364</ArticleId><ArticleId IdType="pubmed">34408485</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C et al (2022) Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis 9:ofac060 10.1093/ofid/ofac060</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ (2021) Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 18:e1003773 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang F, Shen Y et al (2021) Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw Open 4:e2127403 10.1001/jamanetworkopen.2021.27403</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T, Menges D, Anagnostopoulos A et al (2023) Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ 381:e074425. 10.1136/bmj-2022-074425</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu L, Tebe C, Loste C et al (2023) Determinants of the Onset and Prognosis of the Post-COVID-19 Condition: a 2-Year prospective cohort study. Lancet Reg Health Eur 5:10072410.1016/j.lanepe.2023.100724</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100724</ArticleId><ArticleId IdType="pmc">PMC10636281</ArticleId><ArticleId IdType="pubmed">37954002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson SW, Abbafati C, Aerts JG et al (2022) Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 328:1604&#x2013;1615 10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Agergaard J, Gunst JD, Schi&#xf8;ttz-Christensen B, &#xd8;stergaard L, Wejse C (2023) Long-term prognosis at 1.5 years after infection with wild-type strain of SARS-CoV-2 and Alpha, Delta, as well as Omicron variants. Int J Infect Dis 137:126&#x2013;133 10.1016/j.ijid.2023.10.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.10.022</ArticleId><ArticleId IdType="pubmed">37907167</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoja O, Silva Passadouro B, Mulvey M et al (2022) Clinical characteristics and mechanisms of musculoskeletal pain in long COVID. J Pain Res 15:1729&#x2013;1748 10.2147/JPR.S365026</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S365026</ArticleId><ArticleId IdType="pmc">PMC9212788</ArticleId><ArticleId IdType="pubmed">35747600</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvache-Mateo A, Navas-Otero A, Heredia-Ciur&#xf3; A et al (2023) Post-COVID patients with New-Onset Chronic Pain 2 years after Infection: cross-sectional study. Pain Manag Nurs 24:528&#x2013;534 10.1016/j.pmn.2023.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmn.2023.04.010</ArticleId><ArticleId IdType="pmc">PMC10201348</ArticleId><ArticleId IdType="pubmed">37225540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebbesen BD, Giordano R, Valera-Calero JA, Hedegaard JN, Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Arendt-Nielsen L (2024) Prevalence and risk factors of De Novo widespread Post-COVID Pain in Nonhospitalized COVID-19 survivors: a nationwide exploratory Population-based survey. J Pain 25:1&#x2013;11 10.1016/j.jpain.2023.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2023.08.011</ArticleId><ArticleId IdType="pubmed">37633573</ArticleId></ArticleIdList></Reference><Reference><Citation>Oguz-Akarsu E, Gullu G, Kilic E et al (2022) Insight into pain syndromes in acute phase of mild&#x2010;to&#x2010;moderate COVID&#x2010;19: frequency, clinical characteristics, and associated factors. Eur J Pain 26:492&#x2013;504 10.1002/ejp.1876</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1876</ArticleId><ArticleId IdType="pmc">PMC8653127</ArticleId><ArticleId IdType="pubmed">34622527</ArticleId></ArticleIdList></Reference><Reference><Citation>Yurdakul O, Rezvani A, K&#xfc;&#xe7;&#xfc;kakka&#x15f; O, Tolu S, Kili&#xe7;o&#x11f;lu MS, Aydin T (2019) Neuropathic Pain Questionnaire and Neuropathic Pain Questionnaire-Short Form: translation, reliability, and Validation Study of the Turkish version. Turk Neurosurg 29:683&#x2013;688</Citation><ArticleIdList><ArticleId IdType="pubmed">31192441</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause SJ, Backonja M-M (2003) Development of a neuropathic pain questionnaire. Clin J Pain 19:306&#x2013;314 10.1097/00002508-200309000-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002508-200309000-00004</ArticleId><ArticleId IdType="pubmed">12966256</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de&#x2010;las&#x2010;Pe&#xf1;as C, Navarro&#x2010;Santana M, G&#xf3;mez&#x2010;Mayordomo V et al (2021) Headache as an acute and post&#x2010;COVID&#x2010;19 symptom in COVID&#x2010;19 survivors: a meta&#x2010;analysis of the current literature. Eur J Neurol 28:3820&#x2013;3825 10.1111/ene.15040</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15040</ArticleId><ArticleId IdType="pmc">PMC8444899</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Azorin D, Layos-Romero A, Porta-Etessam J et al (2022) Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients. Cephalalgia 42:804&#x2013;809 10.1177/03331024211068074</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211068074</ArticleId><ArticleId IdType="pubmed">35166156</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Bentivegna E, Cho S-J et al (2022) Long COVID headache. J Headache Pain 23:93 10.1186/s10194-022-01450-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelletti P, Bentivegna E, Spuntarelli V, Luciani M (2021) Long-COVID headache. SN Compr Clin Med 3:1704&#x2013;1706 10.1007/s42399-021-00964-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-021-00964-7</ArticleId><ArticleId IdType="pmc">PMC8136258</ArticleId><ArticleId IdType="pubmed">34036244</ArticleId></ArticleIdList></Reference><Reference><Citation>Magdy R, Elmazny A, Soliman SH et al (2022) Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case&#x2013;control study. J Headache Pain 23:101 10.1186/s10194-022-01468-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01468-y</ArticleId><ArticleId IdType="pmc">PMC9372973</ArticleId><ArticleId IdType="pubmed">35962348</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohiuddin Chowdhury ATM, Karim MR, Ali MA, Islam J, Li Y, He S (2021) Clinical characteristics and the long-term post-recovery manifestations of the COVID-19 patients&#x2014;A prospective multicenter cross-sectional study. Front Med (Lausanne) 8:663670 10.3389/fmed.2021.663670</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.663670</ArticleId><ArticleId IdType="pmc">PMC8416537</ArticleId><ArticleId IdType="pubmed">34490284</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares FHC, Kubota GT, Fernandes AM et al (2021) Prevalence and characteristics of new-onset pain in COVID&#x2010;19 survivours, a controlled study. Eur J Pain 25:1342&#x2013;1354 10.1002/ejp.1755</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1755</ArticleId><ArticleId IdType="pmc">PMC8013219</ArticleId><ArticleId IdType="pubmed">33619793</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X et al (2021) 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 398:747&#x2013;758 10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stefano G, Falco P, Galosi E, Di Pietro G, Leone C, Truini A (2023) A systematic review and meta-analysis of neuropathic pain associated with coronavirus disease 2019. Eur J Pain 27:44&#x2013;53 10.1002/ejp.2055</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.2055</ArticleId><ArticleId IdType="pmc">PMC9877974</ArticleId><ArticleId IdType="pubmed">36367322</ArticleId></ArticleIdList></Reference><Reference><Citation>Jena D, Sahoo J, Barman A, Gupta A, Patel V (2022) Musculoskeletal and neurological pain symptoms among hospitalized COVID-19 patients. Am J Phys Med Rehabil 101:411&#x2013;416 10.1097/PHM.0000000000001969</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001969</ArticleId><ArticleId IdType="pmc">PMC9005090</ArticleId><ArticleId IdType="pubmed">35067551</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero-Montes M, Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Ferrer-Pargada D et al (2022) Prevalence of neuropathic component in post-COVID pain symptoms in previously hospitalized COVID-19 survivors. Int J Clin Pract 2022:3532917 10.1155/2022/3532917</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/3532917</ArticleId><ArticleId IdType="pmc">PMC9159239</ArticleId><ArticleId IdType="pubmed">35685491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota GT, Soares FH, da Fonseca AS et al (2023) Pain paths among post-COVID&#x2010;19 condition subjects: a prospective cross&#x2010;sectional study with in&#x2010;person evaluation. Eur J Pain 27:636&#x2013;650 10.1002/ejp.2094</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.2094</ArticleId><ArticleId IdType="pubmed">36799447</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>